LGC tightens pricing again on its KKR buyout loan
LGC, the UK life sciences company being bought by KKR, tightened price guidance on its €350m euro term loan ‘B’ again, after bringing forward its deadline.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: